Co‐Immobilization of ADH and GDH on Metal–Organic‐Framework: An Effective Biocatalyst for Asymmetric Reduction of Ketones

Abstract

Chiral alcohols are not only important building blocks of various bioactive natural compounds and pharmaceuticals, but can serve as synthetic precursors for other valuable organic chemicals, thus the synthesis of these products is of great importance. Bio‐catalysis represents one effective way to obtain these molecules, however, the weak stability and high cost of enzymes often hinder its broad application. In this work, we designed a biological nanoreactor by embedding alcohol dehydrogenase (ADH) and glucose dehydrogenase (GDH) in metal‐organic‐framework ZIF‐8. The biocatalyst ADH&GDH@ZIF‐8 could be applied to the asymmetric reduction of a series of ketones to give chiral alcohols in high yields (up to 99%) and with excellent enantioselectivities (>99%). In addition, the heterogeneous biocatalyst could be recycled and reused at least four times with slight activity decline. Moreover, E. coli containing ADH and GDH was immobilized by ZIF‐8 to form biocatalyst E. coli@ZIF‐8, which also exhibits good catalytic behaviours. Finally, the chiral alcohols are further converted to marketed drugs (R)‐Fendiline, (S)‐Rivastigmine and NPS R‐568 respectively.